Reinhart Partners’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Reinhart Partners’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-327,376	Closed	-$13.8M	–	78
2023 Q2	$13.8M	Sell	327,376 -101,050	-24%	-$4.09M	0.7%	58
2023 Q1	$15.3M	Buy	428,426 +18,160	+4%	+$659K	0.83%	57
2022 Q4	$15M	Buy	410,266 +5,714	+1%	+$226K	0.82%	56
2022 Q3	$19.1M	Buy	404,552 +76,396	+23%	+$4.93M	1.17%	30
2022 Q2	$23.5M	Buy	328,156 +91,151	+38%	+$6.66M	1.29%	26
2022 Q1	$19.2M	Buy	237,005 +7,416	+3%	+$627K	0.93%	48
2021 Q4	$23.6M	Sell	229,589 -68,392	-23%	-$6.57M	1.13%	33
2021 Q3	$26.1M	Sell	297,981 -137,340	-32%	-$12.4M	1.32%	25
2021 Q2	$39M	Buy	435,321 +21,059	+5%	+$1.78M	1.94%	12
2021 Q1	$31.4M	Buy	414,262 +181,442	+78%	+$13.7M	1.63%	21
2020 Q4	$15.9M	Buy	+232,820	New	+$14.5M	0.96%	58

Other funds holding SYNH

Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Natixis Advisors Boston, Massachusetts $71.9B AUM 28.03% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Nomura Asset Management Tokyo, Japan $38.8B AUM 30.94% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

CFB

Cullen/Frost Bankers San Antonio, Texas $8.81B AUM 22.47% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Reinhart Partners's SYNH Position: Q3 2023 in Review

Reinhart Partners sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 327,376 shares — an estimated $13.8M sold.

Reinhart Partners first reported a position in SYNH in Q4 2020 and held it in 11 quarters. The position peaked at $39M in Q2 2021. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

Reinhart Partners reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
Reinhart Partners sold 327,376 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $13.8M.
Reinhart Partners first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2020 and held it in 11 quarters.
Reinhart Partners's Syneos Health, Inc. Class A Common Stock position peaked at $39M in Q2 2021.
10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on Reinhart Partners's 13F filing for Q3 2023, filed 25 Oct 2023.